ライフサイエンスコーパス: euthanasia

1 dard chow diet (4.5% fat) from weaning until euthanasia.

2 35 SIVmac239-infected animals at the time of euthanasia.

3 th, pneumonia, and pyelonephritis, requiring euthanasia.

4 s of the brain with (13)C, followed by rapid euthanasia.

5 ental inoculation of mice presently requires euthanasia.

6 time with live animals without the need for euthanasia.

7 not distinguish between assisted suicide and euthanasia.

8 ent with unremitting pain and 6.5% supported euthanasia.

9 onary injury and continued for 28 days until euthanasia.

10 are becoming increasingly opposed to PAS and euthanasia.

11 ed before drug and at 3 weeks of drug before euthanasia.

12 from patients for assistance with suicide or euthanasia.

13 de, and 4% received one or more requests for euthanasia.

14 oped acute respiratory distress and required euthanasia.

15 (HRP) was administered intravenously before euthanasia.

16 started at 5 days of age and continued until euthanasia.

17 photographs were taken at day 7 before doing euthanasia.

18 ns related to physician-assisted suicide and euthanasia.

19 s of cerebellar ataxia and the owner elected euthanasia.

20 or distress to which mice are exposed during euthanasia.

21 ted at baseline and every 6 to 8 weeks until euthanasia.

22 togenes (Lm) for 36 hours or 72 hours before euthanasia.

23 ull veterinary workup and diagnosis prior to euthanasia.

24 e, first by open surgical biopsy and then by euthanasia.

25 f age, spinal cords were processed following euthanasia.

26 e at 48 h, negative at 72 h, and positive at euthanasia.

27 death or severe clinical signs necessitating euthanasia.

28 Of 58 patients who requested euthanasia, 14 (24%) received parenteral medication and

29 est and control sites at baseline and before euthanasia (16 weeks).

30 After euthanasia, 16 orbits were examined by high-resolution m

31 ng and thickness were assessed and following euthanasia 2-4 wk after serum transfer, paws were prepar

32 day 420 after tick exposure and again before euthanasia, 2 dogs of each group were treated with predn

33 hronic myocardial infarction (3 months), and euthanasia (6.6 months), we measured left ventricular (L

34 ose without (53.8% v 31.7%; P < .001) as did euthanasia (6.8% v 0.9%; P < .001).

35 lls developed disseminated disease requiring euthanasia 73-96 days after injection of cells.

36 When compared to the gradually rising CO(2) euthanasia, addition of a high concentration of N(2)O to

37 on at postinfection (PI) day 28, followed by euthanasia after 1 hour.

38 on dioxide (CO(2)) is the most commonly used euthanasia agent for rodents despite potentially causing

39 At euthanasia, all animals had low to undetectable viral lo

40 At euthanasia, all CD8, but no CD4, Gag epitopes detected d

41 , 3.7% of surveyed oncologists had performed euthanasia and 10.8% had performed physician-assisted su

42 Mice underwent euthanasia and 60 minutes warm ischemia, and lungs were

43 Mice underwent euthanasia and aortic root dissection.

44 Euthanasia and assisted suicide has received considerabl

45 As public debate continues about euthanasia and assisted suicide, some critical care nurs

46 out their attitudes and practices related to euthanasia and assisted suicide.

47 is review focuses on some aspects of PAS and euthanasia and discusses deep terminal sedation (DTS), w

48 ed 6 hours after the final procedure, before euthanasia and formalin perfusion of the NHP; we then pe

49 us exposure to gradually rising CO(2) during euthanasia and hence may reduce the duration of any stre

50 ted on postlaser days 30 and 35, followed by euthanasia and histologic analysis of tissues.

51 iter), and use of less traumatic methods for euthanasia and organ harvest.

52 aluated the stability of attitudes regarding euthanasia and PAS among three cohorts.

53 udies of seriously ill patients' interest in euthanasia and PAS, there are no data on the attitudes a

54 ts (72.6% response rate) were interviewed on euthanasia and PAS.

55 Although euthanasia and physician-assisted suicide (PAS) are cont

56 Euthanasia and physician-assisted suicide (PAS) are high

57 are few data examining the details of actual euthanasia and physician-assisted suicide (PAS) cases in

58 ds of oncology patients and the public found euthanasia and physician-assisted suicide acceptable for

59 Euthanasia and physician-assisted suicide are important

60 Euthanasia and physician-assisted suicide are increasing

61 Requests for euthanasia and physician-assisted suicide are likely to

62 Euthanasia and physician-assisted suicide are pressing p

63 nses to survey questions on attitudes toward euthanasia and physician-assisted suicide for a terminal

64 an increasing and strong public support for euthanasia and physician-assisted suicide has been repor

65 Public support for euthanasia and physician-assisted suicide in the United

66 Oncology patients and the public found euthanasia and physician-assisted suicide least acceptab

67 The practices of euthanasia and physician-assisted suicide remain controv

68 The increasing legalization of euthanasia and physician-assisted suicide worldwide make

69 itting pain, requests for and performance of euthanasia and physician-assisted suicide, and sociodemo

70 eir attitudes and experiences in relation to euthanasia and physician-assisted suicide.

71 rus lacking the leader gene (A12-LLV2), with euthanasia and tissue collection at 24 and 72 h postexpo

72 nd coronary angiography 7 weeks later before euthanasia and tissue harvest.

73 24 and 48 hours after infection, followed by euthanasia and vitreous harvest to quantitate bacterial

74 nship between physician-assisted suicide and euthanasia and withholding or withdrawing life support,

75 assisted suicide for themselves, 85.8% found euthanasia and/or assisted suicide acceptable for their

76 pate in either assisted suicide or voluntary euthanasia, and 13 percent would participate only in ass

77 nt, 23% for assisted suicide, 32% for active euthanasia, and 41% for double effect.

78 requests for physician-assisted suicide and euthanasia, and about 7 percent of those who responded t

79 regoing life-sustaining treatment and active euthanasia, and health professionals' difficulty recogni

80 logical examination because of laceration at euthanasia, and the other PFO was clinically closed, wit

81 available) reported that they had engaged in euthanasia; and an additional 36 (4 percent) reported th

82 In addition, at euthanasia, antigen-specific cells producing gamma inter

83 Physician-assisted suicide and euthanasia are complex moral issues.

84 t request for physician-assisted suicide and euthanasia are not rare.

85 Physician-assisted suicide and euthanasia are topics that engender a strong negative re

86 Caution is warranted regarding PAS and euthanasia, as vulnerable patients may still be at risk.

87 V swarm, while two of four controls required euthanasia at 10 and 11 weeks.

88 eloped a similar disease syndrome, requiring euthanasia at 11 weeks PI of the kittens.

89 controlled their viremia until their time of euthanasia at 200 weeks postchallenge.

90 ved without complication until predetermined euthanasia at 28 days.

91 rTAP and vehicle control was observed after euthanasia at 28 days.

92 or Stx2 (n = 5) in plasma samples from T0 to euthanasia at 49.5 to 128 hours post-challenge.

93 ntially slower increase in proteinuria until euthanasia at 50 wk.

94 nd equal caloric intake was maintained until euthanasia at 7 months.

95 AP or vehicle on day 0 and at 72 hours, with euthanasia at 78 hours after balloon denudation.

96 n day 12 of pregnancy and continuing through euthanasia at day 14 postpartum.

97 After euthanasia at day 60, the esophagus was evaluated visual

98 BrdU was infused for 7 days before euthanasia at days 10, 17, and 38 or during injury and a

99 or both scientific study, humane killing and euthanasia at end of life.

100 avium, and Campylobacter coli that required euthanasia between weeks 100 and 199 p.i.

101 ion and developed clinical disease requiring euthanasia between weeks 12 and 23 postinfection.

102 loss of memory CD4(+) T cells that required euthanasia between weeks 19 and 23 postinfection.

103 Cats that were selected for euthanasia by the shelter staff and additionally had URI

104 e appropriate, treated for depression before euthanasia can be discussed seriously.

105 icians from the End-of-Life Clinic, a mobile euthanasia clinic.

106 ates used, routes and doses of exposure, and euthanasia criteria, all of which may contribute to vari

107 In contradistinction to euthanasia, deactivation of an LVAD does not introduce n

108 Quantitative cultures at euthanasia demonstrated no growth in either SIS group co

109 Repeat catheterization before euthanasia demonstrated statistically significant differ

110 diet, resulting in 50% longer survival until euthanasia, determined by tumor size, of the prenatally

111 eatment or (177)Lu-DOTA-Bn only), leading to euthanasia due to excessive tumor burden, whereas 10 of

112 jected with BrdU (100 mg/kg BID) followed by euthanasia either 24 h or 2 weeks after the last injecti

113 Following euthanasia, femur biomechanics were assessed by 3-point

114 infused stem cells generally require animal euthanasia for single-time-point determinations of engra

115 h documented immunodeficiency at the time of euthanasia, for their capacity to establish durable infe

116 es related to physician-assisted suicide and euthanasia from the perspective of healthcare profession

117 Immediately before euthanasia, half of CW, EW and NW animals were socially

118 hics of physician-assisted suicide (PAS) and euthanasia have been examined in many cross-sectional st

119 Physician-assisted suicide (PAS) and euthanasia have been increasingly discussed in end-of-li

120 ly discussed in end-of-life care, as PAS and euthanasia have now been legalized in three European cou

121 erely tumored stranded turtles that required euthanasia (high FP, 100%, Main Hawaiian Islands).

122 confirmed through infrared imaging and post-euthanasia histology studies via energy-dispersive spect

123 dings (obtained 6 hours after IRE and before euthanasia), histopathologic characteristics, and simula

124 ntly more likely to have seriously discussed euthanasia, hoarded drugs, or read Final Exit.

125 ate regarding physician-assisted suicide and euthanasia holds implications for the practice of critic

126 nction and resulted in death or the need for euthanasia in all seven animals.

127 ore likely to change toward opposing PAS and euthanasia in all vignettes (P <.05).

128 y telephone, regarding acceptance of PAS and euthanasia in four different clinical vignettes.

129 by decreased mortality and prolonged time to euthanasia in macaques.

130 to evaluating physician-assisted suicide and euthanasia in medical practice: 1) the benefit or harm o

131 on related to physician-assisted suicide and euthanasia in the critical care setting.

132 ny studies of physician-assisted suicide and euthanasia in the United States, national data are lacki

133 garding the ethical acceptability of PAS and euthanasia in their follow-up interview.

134 to uniform severe weakness at 24 h requiring euthanasia in untreated animals, anti-C5 mAb-pretreated

135 If euthanasia is delayed, the clinical signs will ascend, c

136 Physician-assisted suicide, excluding euthanasia, is legal in 5 US states (Oregon, Washington,

137 After euthanasia, mLPP was repeated.

138 The method of euthanasia most commonly described was the administratio

139 At euthanasia, MR progressed to moderate to severe in contr

140 progressed more rapidly, with a mean time to euthanasia of 3-6 months.

141 es), or mild (1 macaque) with a mean time to euthanasia of 7 months.

142 ly growing and invasive tumors necessitating euthanasia of all mice by 15 days post injection.

143 CDV FAT to these samples avoids unnecessary euthanasia of dogs with suspected CDV.

144 After euthanasia of female Wistar rats, followed by orbital ex

145 This assay does not require euthanasia of rodents, which is especially important for

146 ty had limited impact on the attitudes about euthanasia of terminally ill cancer patients.

147 e, and lung samples were collected following euthanasia on day 251 p.i.

148 occlusion, after reperfusion, and preceding euthanasia on day 7.

149 s from patients or family members to perform euthanasia or assist in suicide; 129 (16 percent of thos

150 Euthanasia or assisted suicide (EAS) of psychiatric pati

151 agine a situation in which they might desire euthanasia or assisted suicide for themselves but found

152 agine a situation in which they might desire euthanasia or assisted suicide for themselves, 41.7% sti

153 agine a situation in which they might desire euthanasia or assisted suicide for themselves, 85.8% fou

154 When physicians desire euthanasia or assisted suicide for themselves, they are

155 agine a situation in which they might desire euthanasia or assisted suicide for themselves.

156 ients (surrogates), or physicians to perform euthanasia or assisted suicide, as well as their own pra

157 agine a situation in which they would desire euthanasia or assisted suicide.

158 the NA EEEV-infected animals at the time of euthanasia or death.

159 5.6%) had discussed asking the physician for euthanasia or PAS and 6 (2.5%) had hoarded drugs.

160 Most patients (69%) supported euthanasia or PAS for one or more situations.

161 e terminally ill patients who had considered euthanasia or PAS for themselves changed their minds, wh

162 terminally ill patients seriously considered euthanasia or PAS for themselves.

163 ut only 10.6% reported seriously considering euthanasia or PAS for themselves.

164 lly ill patients, a total of 60.2% supported euthanasia or PAS in a hypothetical situation, but only

165 ssociated with being more likely to consider euthanasia or PAS were depressive symptoms (OR, 1.25; 95

166 ssociated with being less likely to consider euthanasia or PAS were feeling appreciated (odds ratio [

167 patient initiate and repeat the request for euthanasia or PAS, (2) ensuring the patient was experien

168 tely, of the 256 decedents, 1 (0.4%) died by euthanasia or PAS, 1 unsuccessfully attempted suicide, a

169 ed comfort from having helped a patient with euthanasia or PAS, 9 (23.7%) regretted having performed

170 or PAS, 9 (23.7%) regretted having performed euthanasia or PAS, and 15 (39.5%) feared prosecution.

171 oth initiated and repeated their request for euthanasia or PAS, but 6 patients (15.8%) did not partic

172 ore likely to change their minds to consider euthanasia or PAS.

173 likely to change their minds about desiring euthanasia or PAS.

174 .8%) did not participate in the decision for euthanasia or PAS.

175 spice care does not obviate their desire for euthanasia or PAS.

176 olute requirements for physicians to perform euthanasia or PAS.

177 e adverse consequences from having performed euthanasia or PAS.

178 cologists described clearly defined cases of euthanasia or PAS.

179 ncologists (15.8%) reported participating in euthanasia or PAS; 53 oncologists (94.6% response rate)

180 staining treament on the one hand and active euthanasia or physician-assisted dying on the other.

181 tial care needs were more likely to consider euthanasia or physician-assisted suicide (P = 0.001).

182 ncology patients had seriously thought about euthanasia or physician-assisted suicide and nearly 12 p

183 that vulnerable patients have been receiving euthanasia or physician-assisted suicide at rates higher

184 Currently, euthanasia or physician-assisted suicide can be legally

185 ing pain--did a majority of oncologists find euthanasia or physician-assisted suicide ethically accep

186 n 0.3% to 4.6% of all deaths are reported as euthanasia or physician-assisted suicide in jurisdiction

187 y experiencing pain were more likely to find euthanasia or physician-assisted suicide unacceptable.

188 ysicians report having received requests for euthanasia or physician-assisted suicide, and 5% or less

189 , 0.71 to 0.87]) were less likely to support euthanasia or physician-assisted suicide.

190 is or her life; and patient consideration of euthanasia or physician-assisted suicide.

191 to 0.95]) were less likely to have performed euthanasia or physician-assisted suicide.

192 deaths in the Netherlands are the result of euthanasia or physician-assisted suicide.

193 rly one in seven oncologists had carried out euthanasia or physician-assisted suicide.

194 alf of oncologists had received requests for euthanasia or physician-assisted suicide.

195 nt needed were more likely to have performed euthanasia (P = 0.001).

196 ve was to assess whether the attitudes about euthanasia/PAS of terminally ill cancer patients were de

197 Statements related to the legalization of euthanasia/PAS were scored using Likert scales.

198 PAS and euthanasia present potential risks for vulnerable popula

199 could be used as a welfare refinement of the euthanasia process in mice, by shortening the duration o

200 terilization of Afro-Germans, and the German euthanasia program.

201 After euthanasia, pulmonary uptake of (18)F-FHBG was determine

202 In patients with cancer, euthanasia rates increased strongly and life-ending acts

203 isolated from four NPs at the time of their euthanasia remained R5 tropic.

204 made available online by the Dutch regional euthanasia review committees as of June 1, 2015.

205 The euthanasia review committees found that one case failed

206 hout independent psychiatric input), but the euthanasia review committees generally defer to the judg

207 w process of the patients' requests, and the euthanasia review committees' assessments of the physici

208 Owners of both dogs elected for euthanasia shortly after the onset of signs.

209 non-human primate has traditionally required euthanasia, significantly limiting the ability to conduc

210 At euthanasia, single tissues of the antibiotic-treated dog

211 associated with attitudes regarding PAS and euthanasia, such as Roman Catholic religion, were not pr

212 Upon euthanasia, T-cell responses were tested from a number o

213 sician-assisted suicide and voluntary active euthanasia than is ordinarily acknowledged.

214 After euthanasia, the jaw segments were evaluated for bone thi

215 After euthanasia, the lung and spleen were removed for pro- an

216 One hour prior to euthanasia, the mice received an intraperitoneal injecti

217 ly physicians could perceive of a desire for euthanasia themselves and whether they would be willing

218 After euthanasia, there were no macroscopically visible lesion

219 After euthanasia, tissue radioactivity was determined in a gam

220 eoxyuridine was administered 24 hours before euthanasia to label proliferating cells.

221 e and immediately after NIMR creation and at euthanasia; vena contracta area, mitral annular dimensio

222 ; P =.001) and more stable responses for all euthanasia vignettes (P <.001) except for pain.

223 sician-assisted suicide and voluntary active euthanasia, voluntarily stopping eating and drinking and

224 During the period from 1998 to 2007, when euthanasia was legalized and palliative care intensified

225 ed by viral burdens, CD4 counts, and time to euthanasia was observed.

226 re injected over the course of 13 weeks, and euthanasia was performed 14 weeks after surgery in both

227 Euthanasia was performed if the serum creatinine concent

228 MLPP after euthanasia was significantly decreased compared to mLPP

229 Agreement with euthanasia was significantly related to male sex, lack o

230 of premature death (death prior to scheduled euthanasia) was assessed.

231 Mandibular block sections obtained after euthanasia were decalcified and embedded in paraffin.

232 y samples or samples obtained at the time of euthanasia were used in this analysis.

233 nd vaginal biopsy samples, and in tissues at euthanasia with an SIV(mac) Gag-specific tetramer.

234 those as a result of symptom alleviation and euthanasia, with a decrease in life-ending acts without

235 herlands, a small number of patients undergo euthanasia without an explicit request.